Join BOPA
Back to news articles

CRUK Consent Form Updates – MPN and Nivolumab with Relatlimab for melanoma

By BOPA Executive Committee on 4th November 2024

Dear All,

I am happy to inform you that the MPN consent forms have been reviewed and updated. Furthermore, a new consent form has been added  form for Nivolumab with Relatlimab for melanoma.

All forms can be found here: www.cruk.org/sact_consent.

Please share this update with your clinical teams or forward to the appropriate lead cancer clinician in your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam (she/her)

Specialist Oncology Pharmacist, CRUK Information Lead

Latest News

By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article
By BOPA Executive Committee on 29th July 2026

Publication ALERT – Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation

BOPA Publication: Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation – Annette (Netty) Cracknell, Dharmisha Chauhan, Lisa Barrott, Emma…

Read article
By BOPA on 24th July 2026

Call for BOPA Award nominations – 1 week left!

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article